122 related articles for article (PubMed ID: 16922709)
1. Established diabetic neuropathy seems irreversible despite improvements in metabolic and vascular risk markers--a retrospective case-control study in a hospital patient cohort.
Coppini DV; Spruce MC; Thomas P; Masding MG
Diabet Med; 2006 Sep; 23(9):1016-20. PubMed ID: 16922709
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Glycated Hemoglobin and Vibration Perception Threshold in Diabetic Peripheral Neuropathy.
Maiya AG; Parameshwar A; Hande M; Nandalike V
Int J Low Extrem Wounds; 2020 Jun; 19(2):120-124. PubMed ID: 31838926
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of vibration perception threshold values in children and adolescents with type 1 diabetes mellitus and associated factors.
Louraki M; Tsentidis C; Kallinikou D; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Papathanasiou A; Karavanaki K
Prim Care Diabetes; 2014 Jul; 8(2):147-57. PubMed ID: 24315733
[TBL] [Abstract][Full Text] [Related]
6. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds.
Coppini DV; Wellmer A; Weng C; Young PJ; Anand P; Sönksen PH
J Clin Neurosci; 2001 Nov; 8(6):520-4. PubMed ID: 11683597
[TBL] [Abstract][Full Text] [Related]
7. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
[TBL] [Abstract][Full Text] [Related]
8. Quantitative vibration perception threshold in assessing diabetic neuropathy: is the cut-off value lower for Indian subjects? [Q-VADIS Study].
Ghosal S; Stephens J; Mukherjee A
Diabetes Metab Syndr; 2012; 6(2):85-9. PubMed ID: 23153975
[TBL] [Abstract][Full Text] [Related]
9. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus.
Pai YW; Lin CH; Lee IT; Chang MH
Diabetes Metab Syndr; 2018; 12(2):111-116. PubMed ID: 29042249
[TBL] [Abstract][Full Text] [Related]
11. Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study.
Rosales-Hernandez A; Cheung A; Podgorny P; Chan C; Toth C
Lipids Health Dis; 2014 Feb; 13():32. PubMed ID: 24520839
[TBL] [Abstract][Full Text] [Related]
12. Strong association between vibration perception thresholds at low frequencies (4 and 8 Hz), neuropathic symptoms and diabetic foot ulcers.
Lindholm E; Löndahl M; Fagher K; Apelqvist J; Dahlin LB
PLoS One; 2019; 14(2):e0212921. PubMed ID: 30817797
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy.
Sharma K N S; Kumar H A
J Foot Ankle Res; 2023 Sep; 16(1):65. PubMed ID: 37770911
[TBL] [Abstract][Full Text] [Related]
14. Does peripheral neuropathy invariably accompany nephropathy in type 1 diabetes mellitus?
Shaw JE; Gokal R; Hollis S; Boulton AJ
Diabetes Res Clin Pract; 1998 Jan; 39(1):55-61. PubMed ID: 9597375
[TBL] [Abstract][Full Text] [Related]
15. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
16. Elevation of von Willebrand factor in plasma in diabetic patients with neuropathic foot ulceration.
Aso Y; Fujiwara Y; Tayama K; Inukai T; Takemura Y
Diabet Med; 2002 Jan; 19(1):19-26. PubMed ID: 11869299
[TBL] [Abstract][Full Text] [Related]
17. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.
Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ
Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between serum cystatin-C levels and vibrating perception threshold in patients with
Type 2 diabetes mellitus].
Yan P; Zhang Z; Xu Y; Wan Q; Ma H; He J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):58-64. PubMed ID: 26819426
[TBL] [Abstract][Full Text] [Related]
19. Validation of bedside methods in evaluation of diabetic peripheral neuropathy.
Jayaprakash P; Bhansali A; Bhansali S; Dutta P; Anantharaman R; Shanmugasundar G; Ravikiran M
Indian J Med Res; 2011 Jun; 133(6):645-9. PubMed ID: 21727664
[TBL] [Abstract][Full Text] [Related]
20. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study.
Coppini DV; Young PJ; Weng C; Macleod AF; Sönksen PH
Diabet Med; 1998 Sep; 15(9):765-71. PubMed ID: 9737806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
